Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-29T22:50:29.163Z Has data issue: false hasContentIssue false

Erectile dysfunction and antipsychotics

Published online by Cambridge University Press:  16 April 2020

F. Fifani
Affiliation:
Psychiatry, Arrazi Psychiatric Hospital, Salé, Morocco
Y. Otheman
Affiliation:
Psychiatry, Arrazi Psychiatric Hospital, Salé, Morocco
M. Outarahout
Affiliation:
Psychiatry, Arrazi Psychiatric Hospital, Salé, Morocco
A. Ouanass
Affiliation:
Psychiatry, Arrazi Psychiatric Hospital, Salé, Morocco

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Sexual side effects associated with antipsychotic medications constitute an understudied set of side effects that diminish a patient's quality of life, and lead to noncompliance with treatment. Male patients frequently report disturbances in erectile and ejaculatory functioning, as well as changes in libido. The capacity to trigger sexual dysfunction differs from one antipsychotic to another. Clinicians prescribing antipsychotic medications should be familiar with the classification, evaluation and treatment of these side effects. The purpose of this study is to assess the occurrence of erectile dysfunction for 5 classes of antipsychotics (Haloperidol, Risperidone, Olanzapine, Amisulpride and Fluphenazine decanoate) in a population of 120 patients, using the International Index of Erectile Dysfunction (IIEF 5).

Type
P03-373
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.